FDA approves cooling cap to reduce hair loss from chemotherapy

In the clinical trial considered by the agency, 7 out of 10 women kept at least 50 percent of their hair during treatment for breast cancer.
A computerized-system pumps cooled liquid through the cap during chemotherapy treatment, causing blood vessels to constrict and slowing cell division in hair follicles, preventing hair loss.
Hair loss has long been a common side effect of chemotherapy but women undergoing the treatment for breast cancer may not have to deal with it for much longer.

The Food and Drug Administration announced its approval of the DigniCap system, a computer-controlled cooling cap that offsets the effects of chemotherapy on hair and minimizes loss.

Read full story here viralsatu.com

Leave a Reply